Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

An Industry Perspective on Harmonization and Implementation of ICH and USP Requirements

November 2, 2012

Pharmaceutical Technology

The US Pharmacopeia's revised General Chapters on elemental impurity limits and testing procedures are set to take effect in December 2012.

A Troubleshooting Guide for Topical Drug Manufacturing

November 2, 2012

Pharmaceutical Technology

Consider critical process parameters and strategies to optimize the manufacturing process.

Examining the Growing Challenge of Extractables and Leachables

November 2, 2012

Pharmaceutical Technology

Experts share insight into extractables and leachables testing, including high-risk products, analytical testing, and regulatory requirements from FDA and EMA.

Optimizing Early-Stage Drug Development

November 2, 2012

Pharmaceutical Technology

Pharmaceutical companies and contract service providers adapt strategies and capabilities to reduce costs and accelerate drug-development timelines.

Novartis Invests US$500 Million in New Biologics Facility in Singapore

October 31, 2012

Novartis is investing more than half a billion US dollars in the construction of a new state-of-the-art biotechnology production site in Singapore for the manufacturing of drugs based on cell culture technology.

Third-Quarter 2012 Financial Reports Show Novartis and Merck Down

October 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.

FDA Issues 483 to New England Compounding Center

October 29, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

New England Compounding Center gets 483 after linked fungal meningitis outbreak.

New USP Standards Guide Prescription Container Labels

October 16, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

New US Pharmacopeial Convention standards provide a universal approach to organizing labels for prescription containers dispensed by US pharmacists in an effort to improve patient understanding.

Novasep to Build the World's Largest Chromatography Plant

October 15, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novasep announced that it will be investing EUR 30 million ($39 million) to build what will be the world's largest chromatography plant for the production of large volumes of commercial APIs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here